Qube Research & Technologies LTD Sarepta Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,598,472 shares of SRPT stock, worth $28.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,598,472

Previous 31,908 4909.63%

Holding current value

$28.5 Million

Previous $2.04 Million 1242.49%

% of portfolio

0.03%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$17.1 - $63.66 $26.8 Million - $99.7 Million	1,566,564 Added 4909.63%	1,598,472 $27.3 Million
Q1 2025 May 15, 2025	BUY	$63.82 - $127.89 $2.04 Million - $4.08 Million	31,908 New	31,908 $2.04 Million
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $997,905 - $1.51 Million	10,650 Added 873.67%	11,869 $1.54 Million
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $63,675 - $118,022	946 Added 346.52%	1,219 $117,000
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $27,982 - $33,740	273 New	273 $33,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $963,636 - $1.52 Million	12,728 New	12,728 $1.41 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $2.2 Million - $2.75 Million	-31,662 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $293,551 - $686,443	-4,063 Reduced 11.37%	31,662 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $4.49 Million - $6.39 Million	35,725 New	35,725 $6.09 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $3.04 Million - $4.12 Million	-23,926 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $2.23 Million - $4.11 Million	23,926 New	23,926 $3.84 Million

Others Institutions Holding SRPT

# of Institutions

418

Shares Held

89.1M

Call Options Held

5.86M

Put Options Held

4.24M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.56B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Sarepta Therapeutics, Inc. Transaction History